As TERT promoter mutations are the most common mutations present in around 60% of HCC patients [33], we analyzed TERT promoter mutations C228T and C250T by ddPCR in order to estimate the ctDNA amount in blood from HCC patients. This evidence concerns the gene TERT and hepatocellular carcinoma.